Introduction

Knee osteoarthritis (OA) is a widespread condition that affects millions of people around the world, often causing pain and making movement difficult. One particular form, patellofemoral osteoarthritis, affects the kneecap joint and brings its own unique challenges, different from the more commonly discussed types of knee OA that affect the inner or outer parts of the knee. Treatments often target these broader types, sometimes overlooking the specific problems caused by OA centred on the kneecap.

People living with patellofemoral OA frequently struggle with everyday activities such as climbing stairs, walking up or down hills, squatting, and cycling – all tasks that can cause pain and restrict mobility. This article looks at how Arthrosamid, a cutting-edge injectable treatment, might offer targeted relief for those with patellofemoral OA. We also explore the expert care available from leading clinicians who specialise in this area.

Understanding Patellofemoral Osteoarthritis

Patellofemoral osteoarthritis occurs when the cartilage underneath the kneecap and the groove on the thigh bone it slides over begin to wear away. This differs from other types of knee OA, which tend to affect the inner or outer compartments of the knee. The kneecap, or patella, plays an important role in knee movement by improving the leverage of the thigh muscles during leg extension.

The typical symptoms of patellofemoral OA include pain and stiffness around the kneecap, especially when performing activities that place extra pressure on this joint – such as climbing stairs, going down slopes, or deep squatting. These symptoms can severely limit daily activities. Unfortunately, this type of OA is often missed or misdiagnosed, leaving many people to suffer longer than necessary.

Arthrosamid: How It Works and Why It Helps Kneecap OA

Arthrosamid is an exciting development in non-surgical treatment for knee osteoarthritis. It is an injectable hydrogel that works by cushioning the joint, helping to restore some of the shock-absorbing function lost as cartilage wears away.

For those with patellofemoral OA, Arthrosamid offers particular benefits. Its cushioning effect helps ease pain during weight-bearing activities such as stair climbing, hill walking and cycling. By improving joint lubrication and smoothing movement, it can help patients move more comfortably and confidently.

Recent research confirms the safety and effectiveness of Arthrosamid, with one study stating it “has been known to be safe and efficacious in knee osteoarthritis patients” (Gao et al., 2025a). Ongoing studies aim to identify which patients benefit most: “which patient factors would allow Arthrosamid to provide the most clinical benefit” (Gao et al., 2025a). Although individual experiences vary, many patients report meaningful reductions in pain and improvements in movement after treatment.

The Importance of Expert Care: Professor Paul Lee and MSK Doctors

The best results with Arthrosamid come from treatment overseen by knowledgeable specialists. Professor Paul Lee is a leading orthopaedic surgeon with a special focus on cartilage repair and joint preservation. His vast experience and patient-centred methods have driven advances in knee OA treatment, including patellofemoral OA. His credentials and accolades underline his commitment to excellent patient care.

MSK Doctors complement this expertise with their modern clinics and evidence-based treatments tailored to musculoskeletal conditions. They prioritise personalised care, offering thorough assessments and custom treatment plans. With experienced clinicians and advanced facilities, MSK Doctors help patients make informed decisions and ensure treatments are safe and effective.

Patient Experience and What to Expect

If you are considering Arthrosamid treatment, expect a detailed consultation to assess whether it’s the right option for you. The procedure itself is minimally invasive and typically carried out under local anaesthetic. Recovery times vary, but patients are encouraged to adjust activities in the weeks following treatment to give the hydrogel time to settle and provide optimum cushioning.

It's important to recognise that research into which patients benefit most is still growing: “the literature surrounding which patients would incur the most benefit from Arthrosamid is limited,” highlighting the need for tailored assessments (Gao et al., 2025a). Many patients report noticeable improvements – greater confidence on stairs, easier squatting and more comfort cycling. These benefits can make a real difference to quality of life. The guidance and support from clinicians like Professor Lee and the MSK Doctors team are key to a positive treatment experience.

Conclusion

Patellofemoral osteoarthritis presents unique difficulties because of its focus on the kneecap joint. Arthrosamid offers a promising, targeted treatment that may reduce pain and improve joint function for those affected, working alongside traditional approaches. Above all, expert care is essential to ensure safe, effective treatment and ongoing support. With continuing research, there is real hope for improving the management of this often-under-recognised condition.

References

• Gao, H. C. K., Akhtar, M., Creedon, C., Nar, Ö. O., Verma, T., & Lee, P. Y. F. (2025). Polyacrylamide hydrogel injections in knee osteoarthritis: A PROMs-based 24 month cohort study. Journal of Clinical Orthopaedics and Trauma. https://doi.org/10.1016/j.jcot.2025.103136
• Gao, H. C. K., Akhtar, M., Creedon, C., Nar, Ö. O., & Lee, P. Y. F. (2025a). The impact of patient factors on the minimal clinically important difference of Arthrosamid polyacrylamide hydrogel injection for knee osteoarthritis: A cohort study. Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2025.02.648